Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

127.06 -1.06 (-0.82%)

Streaming Delayed Price Updated: 9:46 AM EST, Nov 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

50 51 Next >

Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years ↗

November 30, 2023

Via Benzinga

Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality' ↗

November 30, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vishay Intertechnology, Inc.

Via Benzinga

Medtronic: oversold, overextended high yield reversal in play

November 22, 2023

The reversal in Medtronic has been brewing for some time but is gaining traction after strong second quarter earnings that came with improved guidance

Via MarketBeat

Magnificent 7 Take Center Stage In Hedge Fund Portfolios: Analysts Warn Of Extreme Concentration ↗

November 21, 2023

Hedge fund portfolios are intensifying their focus on technology stocks, with holdings in mega-cap tech reaching record levels.

Via Benzinga

1 Stock Down 15% This Year to Buy and Hold Forever ↗

November 02, 2023

This stock has been delivering solid performances for a long time.

Via The Motley Fool

2 No-Brainer Dividend Stocks to Buy This Week ↗

October 30, 2023

These two top-income stocks are too cheap to ignore.

Via The Motley Fool

(ABT) - Analyzing Abbott Laboratories's Short Interest ↗

October 23, 2023

Via Benzinga

Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How. ↗

November 20, 2023

New medicines for weight loss and diabetes stand to disrupt the competitive scene.

Via The Motley Fool

Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029

November 17, 2023

EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END

Via FinancialNewsMedia

3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing ↗

November 14, 2023

You'll be happy to own these top companies in any market environment.

Via The Motley Fool

Novo Nordisk, Eli Lilly Skid — But These Weight-Loss Results Are 'Hard To Ignore' ↗

November 13, 2023

Patients who took Wegovy for five years had a 70% reduced risk of developing diabetes.

Via Investor's Business Daily

2 No-Brainer Stocks to Buy for Forever Dividend Growth ↗

November 09, 2023

These companies generate billions of dollars in free cash flow every year.

Via The Motley Fool

2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity ↗

November 08, 2023

Investors could be making a mistake by selling off these stocks this year.

Via The Motley Fool

8 Health Care Stocks Whale Activity In Today's Session ↗

November 07, 2023

Via Benzinga

3 Dividend Kings to Buy for Royal Returns ↗

November 06, 2023

Unlock the secrets of dividend kings, the aristocrats of the stock market with unparalleled records of raising dividends yearly.

Via InvestorPlace

Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever ↗

November 04, 2023

Dividend stocks can cushion your portfolio in times of market trouble.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

November 02, 2023

Via Benzinga

3 Dividend Stocks That Are Investor Safe Havens ↗

November 02, 2023

If there is such a thing as safe dividend stocks, these three should be at the top of your list to consider.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

October 31, 2023

Via Benzinga

SLB, Abbott And 2 Other Stocks Insiders Are Selling ↗

October 31, 2023

The Nasdaq 100 closed higher by over 1% on Monday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

MedTech Giant DexCom Spotlight Is On G7 US Launch, Analyst Forecasts 22% Revenue Gain In 2024 ↗

October 27, 2023

Oppenheimer analyst Steven Lichtman reiterated the Outperform rating on DexCom, Inc.

Via Benzinga

Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond ↗

October 26, 2023

The market has punished them, but don't overlook these stocks.

Via The Motley Fool

Are These 3 Dividend Aristocrats Undervalued Hidden Gems?

October 25, 2023

Dividend aristocrats Caterpillar, NextEra, and Clorox have shown resilience in challenging times. These may offer opportunities as they are trading off highs.

Via MarketBeat

Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S. ↗

October 24, 2023

Abbott Laboratories is getting into the consumer wearables market.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 23, 2023

Via Benzinga

Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield... ↗

October 23, 2023

The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at...

Via Talk Markets

Topics Economy

The Value Deepens for Medtech Stocks: Reversal Imminent

October 23, 2023

MedTech stocks are performing well and supported by pent-up demand, yet share prices are trading at significant and often historical lows.

Via MarketBeat

Stock Market Struggles As Treasury Yields Soar; Tesla, Nvidia Among Notable Losers: Weekly Review ↗

October 20, 2023

The major indexes saw significant loses as Treasury yields soared.

Via Investor's Business Daily

7 Blue-Chip Stocks to Buy on the Dip ↗

October 19, 2023

While you can find plenty of ideas swimming in red ink, investors may find greater success with blue-chip stocks to buy on the dip.

Via InvestorPlace

These Analysts Cut Their Forecasts On Abbott After Q3 Results ↗

October 19, 2023

Abbott Laboratories (NYSE: ABT) reported better-than-expected third-quarter results.

Via Benzinga

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions